Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Mar 2;13(2):460–463. doi: 10.1016/j.radcr.2018.02.005

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Fig. 1 — Contrast-enhanced computed tomography (CT) of a patient with erythrodermic psoriasis. (A) Three-dimensional (3D)-CT image before infliximab treatment revealing systemic vasodilatation and bilateral axillary (wide arrow) and inguinal (narrow arrow) lymphadenopathy. (B) 3D-CT image after infliximab treatment. Improvement of vasodilatation and lymphadenopathy is apparent. (C) Axial CT image before treatment revealing vasodilatation, diffuse skin thickening, and subcutaneous fat stranding (arrowheads). (D) Follow-up axial CT after treatment revealing improvement of these imaging findings. (E, G) Contrast-enhanced CT before treatment revealing lymphadenopathy of axillary (wide arrow) and inguinal regions (narrow arrow). Note the thickened skin and subcutaneous fat stranding (arrowheads). (F, H) Follow-up CT after treatment revealing improvement of these findings.